BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32925477)

  • 1. Opsoclonus-Myoclonus-Ataxia Syndrome Related to the Novel Coronavirus (COVID-19).
    Sanguinetti SY; Ramdhani RA
    J Neuroophthalmol; 2021 Sep; 41(3):e288-e289. PubMed ID: 32925477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis.
    Urrea-Mendoza E; Okafor K; Ravindran S; Absher J; Chaubal V; Revilla FJ
    Tremor Other Hyperkinet Mov (N Y); 2021 Feb; 11():7. PubMed ID: 33614199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsoclonus-Myoclonus-Ataxia Syndrome Due to Covid-19.
    Adamaszek M; Langner S; Mehrholz J; Heiinrich A
    Cerebellum; 2024 Jun; 23(3):1245-1248. PubMed ID: 37814146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsoclonus myoclonus ataxia syndrome following COVID-19 infection.
    Ismail II; Kamel WA; Kilany A
    Acta Neurol Belg; 2023 Apr; 123(2):715-716. PubMed ID: 35836090
    [No Abstract]   [Full Text] [Related]  

  • 5. Opsoclonus myoclonus ataxia syndrome in severe acute respiratory syndrome coronavirus-2.
    Fernandes J; Puhlmann P
    J Neurovirol; 2021 Jun; 27(3):501-503. PubMed ID: 33788141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
    Emamikhah M; Babadi M; Mehrabani M; Jalili M; Pouranian M; Daraie P; Mohaghegh F; Aghavali S; Zaribafian M; Rohani M
    J Neurovirol; 2021 Feb; 27(1):26-34. PubMed ID: 33492608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsoclonus Myoclonus Ataxia Syndrome in the Setting of COVID-19 Infection.
    Shah PB; Desai SD
    Neurology; 2021 Jan; 96(1):33. PubMed ID: 33004603
    [No Abstract]   [Full Text] [Related]  

  • 8. 78-year-old woman with opsoclonus myoclonus ataxia syndrome secondary to COVID-19.
    Saha B; Saha S; Chong WH
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34049895
    [No Abstract]   [Full Text] [Related]  

  • 9. Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome.
    Przytuła F; Błądek S; Sławek J
    Neurol Neurochir Pol; 2021; 55(3):310-313. PubMed ID: 34096013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome.
    Deniz A; Alikılıç D; Öztürk M; Karaca Ö; Güngör M; Kara B
    J AAPOS; 2023 Apr; 27(2):110-112. PubMed ID: 36736453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute cerebellar ataxia and myoclonus with or without opsoclonus: a para-infectious syndrome associated with COVID-19.
    Foucard C; San-Galli A; Tarrano C; Chaumont H; Lannuzel A; Roze E
    Eur J Neurol; 2021 Oct; 28(10):3533-3536. PubMed ID: 33492711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postinfectious SARS-CoV-2 Opsoclonus-Myoclonus-Ataxia Syndrome.
    Nelson JL; Blume GM; Bansal SK; Kaufman JR; Woods FR; Zhang X; Kattah JC
    J Neuroophthalmol; 2022 Jun; 42(2):251-255. PubMed ID: 34974489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome.
    Altunsoy A; Kemirtlek N; Araz H; Dirik EB; Akıncı E
    J Infect Dev Ctries; 2024 Feb; 18(2):188-194. PubMed ID: 38484346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal Changes in Brain Perfusion in a Patient with Myoclonus and Ataxia Syndrome Associated with COVID-19.
    Osawa K; Sugiyama A; Uzawa A; Hirano S; Yamamoto T; Nezu M; Araki N; Kano H; Kuwabara S
    Intern Med; 2022 Apr; 61(7):1071-1076. PubMed ID: 35110499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy responsive SARS-CoV-2 infection exacerbating opsoclonus myoclonus syndrome.
    Wiegand SE; Mitchell WG; Santoro JD
    Mult Scler Relat Disord; 2021 May; 50():102855. PubMed ID: 33677410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsoclonus-myoclonus syndrome attributable to West Nile encephalitis: a case report.
    Bîrluţiu V; Bîrluţiu RM
    J Med Case Rep; 2014 Jun; 8():232. PubMed ID: 24968889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare case of opsoclonus myoclonus syndrome following COVID-19 illness.
    Shil R; Dunai C; Seed A; Wood G; Collie C; Pendered S; Bonello M; Elsone L; Michael B
    Clin Med (Lond); 2023 Nov; 23(Suppl 6):40. PubMed ID: 38182203
    [No Abstract]   [Full Text] [Related]  

  • 18. Opsoclonus-myoclonus syndrome attributable to hepatitis C infection.
    Ertekin V; Tan H
    Pediatr Neurol; 2010 Jun; 42(6):441-2. PubMed ID: 20472199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsoclonus-Myoclonus in COVID-19 Infection. A Known Clinical Presentation in New Disease.
    Kini TA; Guduru Z
    J Neuroophthalmol; 2022 Jun; 42(2):e526. PubMed ID: 35421031
    [No Abstract]   [Full Text] [Related]  

  • 20. [Small cell lung cancer complicated by opsoclonus myoclonus syndrome].
    Iwata T; Yokomura I; Ohsugi S; Uesaka A; Sekiguchi K; Nishio A
    Nihon Kokyuki Gakkai Zasshi; 2009 Nov; 47(11):1046-50. PubMed ID: 19994603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.